(Q36628019)

15 August 2017

Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy (English)

1 reference

15 August 2017

anti-retroviral agent

0 references

0 references

14

1 reference

Nagalingeswaran Kumarasamy

15 August 2017

Elena Losina

3

0 references

2

object named as

Nagalingeswaran Kumarasamy

1 reference

15 August 2017

9

Milton C Weinstein

1 reference

15 August 2017

1

Kenneth A Freedberg

1 reference

15 August 2017

13

Kenneth H Mayer

1 reference

15 August 2017

5

Callie A Scott

1 reference

15 August 2017

10

Bingxia Wang

1 reference

15 August 2017

7

Timothy P Flanigan

1 reference

15 August 2017

Anitha J Cecelia

4

1 reference

15 August 2017

Nomita Divi

6

1 reference

15 August 2017

Zhigang Lu

8

1 reference

15 August 2017

Aylur K Ganesh

11

1 reference

15 August 2017

Melissa A Bender

12

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

15 August 2017

1 reference

15 August 2017

21 Suppl 4

1 reference

15 August 2017

S117-28

1 reference

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

HIV drug resistance surveillance for prioritizing treatment in resource-limited settings

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

The TREAT Asia HIV Observational Database: baseline and retrospective data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Usefulness of an observational database to assess antiretroviral treatment trends in India.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Natural history of human immunodeficiency virus disease in southern India

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

The cost effectiveness of combination antiretroviral therapy for HIV disease.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2365748

Effect of Highly Active Antiretroviral Therapy on Time to Acquired Immunodeficiency Syndrome or Death using Marginal Structural Models

20 September 2018

1 reference

12 December 2020

The world health report 2002 - reducing risks, promoting healthy life

1 reference

12 December 2020

Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India

1 reference

12 December 2020

The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India

1 reference

12 December 2020

Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options

1 reference

12 December 2020

HIV in India--the challenges ahead

1 reference

12 December 2020

The economics of effective AIDS treatment in Thailand

1 reference

12 December 2020

10.1097/01.AIDS.0000279714.60935.A2

Identifiers

DOI

1 reference

release_j4w4bxxlhvbrxmlkx6uqttqk6y

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j4w4bxxlhvbrxmlkx6uqttqk6y

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

17620747

1 reference